Skip to main content

OGN

Stock
Health Care
Drug Manufacturers - General

Performance overview

OGN Price
Price Chart

Forward-looking statistics

Beta
0.52
Risk
40.14%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

organon is a dutch pharmaceutical company started in oss the netherlands. it is famous for 'the pil' a birthcontrol pil. organon grew as a company and was taken over by schering plough and later on by merck and continues as msd in the netherlands. in the old days the compant was great, it used to be 'gezellig' !

Company info

SectorHealth Care
IndustryDrug Manufacturers - General
Employees9K
Market cap$5.3B

Fundamentals

Enterprise value$10.9B
Revenue$6.3B
Revenue per employee—
Profit margin11.92%
Debt to equity1652.40

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)$2.88
Dividend per share$1.12
Revenue per share$24.43
Avg trading volume (30 day)$42M
Avg trading volume (10 day)$35M
Put-call ratio—

Macro factor sensitivity

Growth-0.2
Credit+4.2
Liquidity-1.4
Inflation-1.7
Commodities+0.7
Interest Rates-1.3

Valuation

Dividend yield11.24%
PEG Ratio2.35
Price to sales0.41
P/E Ratio2.35
Enterprise Value to Revenue1.74
Price to book4.74

Upcoming events

Next earnings dayMay 1, 2025
Next dividend day—
Ex. dividend dayMay 12, 2025

News

OGN or MEDP: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical Services sector might want to consider either Organon (OGN) or Medpace (MEDP). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research (July 21, 2025)
Organon (OGN) Outperforms Broader Market: What You Need to Know

Organon (OGN) closed the most recent trading day at $10.02, moving +1.11% from the previous trading session.

Zacks Investment Research (July 10, 2025)
Trade Tracker: Jenny Harrington sells Organon and buys Vici Properties

Jenny Harrington, CEO Gilman Hill Asset Management, joins CNBC's "Halftime Report" to detail her latest portfolio moves.

CNBC Television (July 8, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free